Skip to main navigation Skip to search Skip to main content

Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation

  • Ajay K. Gopal
  • , Radhakrishnan Ramchandren
  • , Owen A. O'Connor
  • , Robert B. Berryman
  • , Ranjana H. Advani
  • , Robert Chen
  • , Scott E. Smith
  • , Maureen Cooper
  • , Achim Rothe
  • , Jeffrey V. Matous
  • , Laurie E. Grove
  • , Jasmine Zain
  • University of Washington
  • Karmanos Cancer Institute, Detroit, MI;
  • Columbia University Medical Center
  • Baylor University Medical Center
  • Stanford University
  • City of Hope National Medical Center
  • Loyola University Chicago
  • St Francis Hospital and Medical Center, Beech Grove, IN;
  • University Hospital of Cologne, Cologne, Germany;
  • Colorado Blood Cancer Institute, Denver, CO;
  • Seattle Genetics
  • New York University

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume120
Issue number3
DOIs
StatePublished - Jul 19 2012
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Surgery
  • Internal Medicine

Cite this